関連する実験動画

Updated: Sep 9, 2025

Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.6K

HomoPROTACKeap1:アレルギー性鼻炎に対するKeap1の化学的なノックダウンの新しい戦略

Xiaofeng Qi1

  • 1Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Acta pharmaceutica Sinica. B
|September 2, 2025
PubMed
まとめ

No abstract available in PubMed .

キーワード:
アレルギー性鼻炎ホモプロタックキープ1Nrf2 について

さらに関連する動画

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

1.9K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

661

関連する概念動画

Allergic Reactions02:06

Allergic Reactions

Overview
28.5K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
461